It has been reported that CXCL5 expression has been used as a prognosis predictor that is related to poor prognosis in many cancers, such as prostate cancer, endometrial cancer, hepatocellular carcinoma, and pancreatic cancer31,32. Here, CXCL5 is linked to prostate carcinoma.